2026 ICD-10-CM Diagnosis Code D56.5Hemoglobin E-beta thalassemia

ICD-10-CM CodesD50–D89D55-D59D56

ICD-10-CM D56.5
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D56.5 is a billable ICD-10-CM diagnosis code for hemoglobin E-beta thalassemia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 791, 793, 811 through 812. Coders also document this condition as hemoglobin E beta plus thalassemia. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Hemolytic anemia.

For Medicare Advantage risk adjustment, D56.5 maps to CMS-HCC Category 108 (Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major) under the V28 model, adding a risk factor of about 0.146 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
D56.5
Billable Status
Yes — Valid for Submission
Code Describes
Hemoglobin E-beta thalassemia
Short Description
Hemoglobin E-beta thalassemia
Same as the full description in the CMS dataset.
Parent Code
Thalassemia

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD55-D59Hemolytic anemias
CategoryD56Thalassemia
This CodeD56.5Hemoglobin E-beta thalassemia

Medicare Risk Adjustment (HCC)Billing

D56.5 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 108— Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major
Payment HCC · PY 2026 one of 39 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.146
community, non-dual, aged · ranges 0.098–0.416 across segments
Hierarchy
Superseded by HCC 107
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 48
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 48 · ESRD (V21): HCC 48 · ESRD (V24): HCC 48
ESRD V21 weights: 0.059 dialysis, 0.173–0.234 functioning graft · ESRD V24 weights: 0.063 dialysis, 0.192–0.358 functioning graft
Part D (RxHCC)
Not mapped
D56.5 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Hemoglobin E beta plus thalassemia
  • Hemoglobin E beta zero thalassemia
  • Hemoglobin E disease
  • Hemoglobin E/beta thalassemia disease

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Type 1 Excludes

  • beta thalassemia D56.1
  • beta thalassemia minor D56.3
  • beta thalassemia trait D56.3
  • delta-beta thalassemia D56.2
  • delta-beta thalassemia trait D56.3
  • hemoglobin E disease D58.2
  • other hemoglobinopathies D58.2
  • sickle-cell beta thalassemia D57.4

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD002
Hemolytic anemia
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Hemoglobin E Disease

    a condition characterized by the presence of a variant of normal hemoglobin (hemoglobin e), which is caused by mutation(s) in the gene encoding the beta subunit of the hemoglobin molecule.
  • Sickle Cell-Hemoglobin E Disease|Hemoglobin SE Disease

    a variant of sickle cell disease due to heterozygosity for hemoglobin s and hemoglobin e mutations. patients present with the symptoms of sickle cell disease but the symptoms are less frequent and severe compared to patients with hemoglobin ss disease.

Patient EducationClinical

Thalassemia

Thalassemias are inherited blood disorders. If you have one, your body makes fewer healthy red blood cells and less hemoglobin. Hemoglobin is a protein that carries oxygen to the body. That leads to anemia. Thalassemias occur most often among people of Italian, Greek, Middle Eastern, Southern Asian, and African descent.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D56.5 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
282.47 Hgb E-beta thalassemia
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D56.5Overview

What is the ICD-10 code for hemoglobin E-beta thalassemia?

The ICD-10-CM code for hemoglobin E-beta thalassemia is D56.5 (sometimes written as D565). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is D56.5 (Thalassemia) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report hemoglobin E-beta thalassemia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D56.5 group to?

When hemoglobin E-beta thalassemia is the principal diagnosis on an inpatient stay, it groups to MS-DRG 791, 793, 811, 812, with relative weights from 0.9182 to 4.1696 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D56.5?

Under the General Equivalence Mappings, hemoglobin E-beta thalassemia converts to ICD-9-CM 282.47 (hgb E-beta thalassemia). The mapping is a direct match.

What HCC is D56.5?

D56.5 (hemoglobin E-beta thalassemia) maps to CMS-HCC Category 108 (Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major), commonly written as HCC 108, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 48 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.

Does D56.5 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, D56.5 adds a risk adjustment factor of about 0.146 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.098 to 0.416 depending on the payment segment). A more severe related category (HCC 107) supersedes it when both are reported. See the full factor table on the HCC 108 category page.